Previous Funding

Previous Funding

NIH/NHLBI (R01 HL092953). Adenosine receptor activation and lung ischemia reperfusion injury.
Victor Laubach and Irving Kron, MD (MPI). 08/2008 - 03/2013.

Roche Organ Transplant Research Foundation, Meggen, Switzerland (Research Grant). Attenuation of lung reperfusion injury by adenosine A2A receptor activation.
Victor Laubach (PI). 02/2009 - 01/2011.

NIH/NHLBI (RO1 HL077301). Resident Leukocytes in Lung Ischemia-Reperfusion Injury.
Victor Laubach(PI). 05/2005 – 04/2010.

NIH/NHLBI (RO1 HL56093). Protection of the pulmonary vascular endothelium.
Irving Kron (PI). 07/1997 - 06/2007.

NIH/NHLBI (RO1 HL67780). Nitric oxide regulation of compensatory lung growth.
Victor Laubach (PI). 04/2002 - 03/2007.

American Lung Association (Career Investigator Award). Mechanisms of unequal lobar growth in post-pneumonectomy lung growth.
Victor E. Laubach, PhD (PI). 07/2003 - 06/2006.

Commonwealth Neurotrama Initiative, Virginia Dept of Rehabilitative Services. Adenosine A2A Agonists in the Treatment of Acute Spinal Cord Injury.
John Kern (PI). 8/1/2002 -7/30/2005.

Falk Medical Research Trust (Research Grant). Role of inflammation in serious and incurable diseases.
Irving Kron (PI). 01/2001 - 12/2004.

American Heart Association (Grant in Aid). Lung protection following transplantation.
Irving Kron (PI). 01/2002 - 12/2004.

Virginia Thoracic Society (Research Grant). Nitric oxide regulation of compensatory lung growth.
Victor Laubach (PI). 07/2001 - 6/2003.

NIH/NHLBI (RO1 HL4824). Living related pulmonary lobar transplantation.
Irving Kron (PI). 04/1993 - 03/2002.

American Heart Association. Mechanisms of cellular growth in reduced-size lung transplantation.
Victor Laubach (PI). 07/1999 - 06/2001.